Search

State

Industry

Company

AGRICULTURE CHEMICALS

- INVESTOR AGREEMENT (JANUARY 2018)

Mosaic Co

- INVESTOR AGREEMENT (JANUARY 2018) INVESTOR AGREEMENT among THE MOSAIC COMPANY, VALE S.A. and VALE FERTILIZER NETHERLANDS B.V. DATED AS OF JANUARY 8, 2018 TABLE OF CONTENTS Page BACKGROUND 1 ARTICLE I DEFINITIONS 1 SECTION 1.01 Certain Defined Terms 1 SECTION 1.02 Other Definitional Provisions; Interpretation 6 ARTICLE II CORPORATE GOVERNANCE 7 SECTION 2.01 Board Representation 7 SECTION 2.02 Co

RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT

Investor Agreement

Aviat Networks, Inc.

INVESTOR AGREEMENT Investor Agreement Table of Contents INVESTOR AGREEMENT Between HARRIS CORPORATION and HARRIS STRATEX NETWORKS, INC. Dated: January 26, 2007 E-1 Table of Contents TABLE OF CONTENTS ARTICLE I Definitions and Construction 1.1. Certain Definitions E-4 1.2. Additional Definitions E-6 1.3. Terms Generally E-6 ARTICLE II Scope of Agreement 2.1. Scope of Agreement E-7 2.2. Governing I

SERVICES-PREPACKAGED SOFTWARE

Investor Agreement

Activision Blizzard, Inc.

AMENDED AND RESTATED INVESTOR AGREEMENT THIS AMENDED AND RESTATED INVESTOR AGREEMENT, dated as of October 11, 2013 (this “ Agreement ”), is between VIVENDI, S.A., a societe anonyme organized under the laws of France (“ Vivendi ”), VIVENDI HOLDING I LLC (as successor to VGAC LLC, a Delaware limited liability company), a Delaware limited liability company (“ VHI LLC ” and together with Vivendi, the

RETAIL-HOBBY, TOY & GAME SHOPS

October 11, 2019 The Michaels

Armour Residential Reit, Inc.

October 11, 2019 The Michaels Companies, Inc. 8000 Bent Branch Drive Irving, Texas 75063 Ladies and Gentlemen: Reference is made to the Investor Agreement, dated as of June 26, 2014 (the “Investor Agreement”), by and among The Michaels Companies, Inc., a Delaware corporation (together with its successors and permitted assigns, the “Company”), and each Person that executed the Investor Agreement a

SEARCH, DETECTION, NAVIGATION, GUIDANCE, AERONAUTICAL SYS

Investor Agreement

L3Harris Technologies, Inc. /De/

INVESTOR AGREEMENT Investor Agreement Table of Contents INVESTOR AGREEMENT Between HARRIS CORPORATION and HARRIS STRATEX NETWORKS, INC. Dated: January 26, 2007 E-1 Table of Contents TABLE OF CONTENTS ARTICLE I Definitions and Construction 1.1. Certain Definitions E-4 1.2. Additional Definitions E-6 1.3. Terms Generally E-6 ARTICLE II Scope of Agreement 2.1. Scope of Agreement E-7 2.2. Governing I

SERVICES-PREPACKAGED SOFTWARE

Investor Agreement

Activision Blizzard, Inc.

INVESTOR AGREEMENT THIS INVESTOR AGREEMENT, dated as of July 9, 2008 (this “ Agreement ”), is between VIVENDI S.A., a societe anonyme organized under the laws of France (“ Vivendi ”), VGAC LLC, a Delaware limited liability company (“ VGAC LLC ”; and together with Vivendi, the “ Vivendi Stockholders ”), VIVENDI GAMES, INC., a Delaware corporation and wholly owned subsidiary of VGAC LLC (“ Games ”)

OPERATORS OF NONRESIDENTIAL BUILDINGS

INVESTOR AGREEMENT FOR SALE OF SHARES (PDC)

Corix Bioscience, Inc.

INVESTOR AGREEMENT FOR SALE OF SHARES (PDC)

PHARMACEUTICAL PREPARATIONS

alny-ex105_536.htm

Alnylam Pharmaceuticals, Inc.

alny-ex105_536.htm Confidential AMENDED AND RESTATED INVESTOR AGREEMENT By and Between GENZYME CORPORATION AND ALNYLAM PHARMACEUTICALS, INC. Dated as of April 8, 2019 CERTAIN CONFIDENTIAL PORTIONS OF THIS HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF

AGRICULTURE CHEMICALS

FORM OF INVESTOR AGREEMENT

Mosaic Co

D FORM OF INVESTOR AGREEMENT among THE MOSAIC COMPANY, [ ● ] and VALE S.A. DATED AS OF [ ● ] TABLE OF CONTENTS Page BACKGROUND 1 Article I DEFINITIONS 1 SECTION 1.01 Certain Defined Terms 1 SECTION 1.02 Other Definitional Provisions; Interpretation 6 Article II CORPORATE GOVERNANCE 6 SECTION 2.01 Board Representation 6 SECTION 2.02 Corporate Opportunities 9 SECTION 2.03 Transfer of Rights; Loss o

PHARMACEUTICAL PREPARATIONS

nktr-ex41_103.htm

Nektar Therapeutics

nktr-ex41_103.htm INVESTOR AGREEMENT This INVESTOR AGREEMENT (this “ Agreement ”) is made as of February 13, 2018, by and between Bristol-Myers Squibb Company, a Delaware corporation (the “ Investor ”), and Nektar Therapeutics, a Delaware corporation (the “ Company ”). WHEREAS, concurrently with the entering into of this Agreement, the Company and the Investor are entering into that certain Strat